Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • nans_bn
    Member
    • Mar 2011
    • 12

    #1

    het:hom distribution in case-control study

    Hello,
    I am working on case-control study and would like to understand how to calculate and interpret the hom/het ratio distribution of the minor allele. A test data generated from plink --model is as follows

    Code:
    CHR SNP A1 A2 TEST     AFF             UNAFF       P
    
    1  snp1 A1 A2 GENO     0/25/1465     0/35/1010   0.008
    
    1  snp1 A1 A2 TREND    25/2955       35/2060     0.005
    
    1  snp1 A1 A2 ALLELIC  25/2955       35/2060     0.01
    
    1  snp1 A1 A2 DOM      25/1465       35/1010     0.009
    
    1  snp1 A1 A2 REC      0/1490        0/1050      1
    
    2  snp2 A1 A2 GENO     75/230/1250   9/140/890   1.6e-05
    
    2  snp2 A1 A2 TREND    380/2730      158/1925    2.6e-03
    
    2  snp2 A1 A2 ALLELIC  380/2730      158/1925    1.0e-06
    
    2  snp2 A1 A2 DOM      305/1250      149/890     0.0004
    
    2  snp2 A1 A2 REC      75/1480       9/1035      2.2e-2
    What I assume is that snp2 shows the best p value in the recessive model so I would assume there are more homozygous alleles than expected. And snp1 shows a stronger dominant effect so there could be more heterozygous alleles. But how can I know if the distribution of aa/aA/AA is correct and this data can be analysed further?

    Thank you..
    Last edited by nans_bn; 11-26-2013, 02:24 AM.

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
23 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
20 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
36 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
42 views
0 reactions
Last Post SEQadmin2  
Working...